Haight, P. J., Sanchez, M., Thomas, S. M., Smitherman, C., Cosgrove, C., Bae-Jump, V., Crafton, S., Hacker, K., Ko, E., Krivak, T., Lara, O., Moore, K., Mullen, M. M., Pothuri, B., Thaker, P. H., Washington, C., Arend, R., Corr, B., Duska, L., … Backes, F. (2025). Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study. Gynecologic Oncology, 194, 98–104. https://doi.org/10.1016/j.ygyno.2025.02.013